Back to Search Start Over

An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma.

Authors :
Hasanov E
Yeboa DN
Tucker MD
Swanson TA
Beckham TH
Rini B
Ene CI
Hasanov M
Derks S
Smits M
Dudani S
Heng DYC
Brastianos PK
Bex A
Hanalioglu S
Weinberg JS
Hirsch L
Carlo MI
Aizer A
Brown PD
Bilen MA
Chang EL
Jaboin J
Brugarolas J
Choueiri TK
Atkins MB
McGregor BA
Halasz LM
Patel TR
Soltys SG
McDermott DF
Elder JB
Baskaya MK
Yu JB
Timmerman R
Kim MM
Mut M
Markert J
Beal K
Tannir NM
Samandouras G
Lang FF
Giles R
Jonasch E
Source :
CA: a cancer journal for clinicians [CA Cancer J Clin] 2022 Sep; Vol. 72 (5), pp. 454-489. Date of Electronic Publication: 2022 Jun 16.
Publication Year :
2022

Abstract

Brain metastases are a challenging manifestation of renal cell carcinoma. We have a limited understanding of brain metastasis tumor and immune biology, drivers of resistance to systemic treatment, and their overall poor prognosis. Current data support a multimodal treatment strategy with radiation treatment and/or surgery. Nonetheless, the optimal approach for the management of brain metastases from renal cell carcinoma remains unclear. To improve patient care, the authors sought to standardize practical management strategies. They performed an unstructured literature review and elaborated on the current management strategies through an international group of experts from different disciplines assembled via the network of the International Kidney Cancer Coalition. Experts from different disciplines were administered a survey to answer questions related to current challenges and unmet patient needs. On the basis of the integrated approach of literature review and survey study results, the authors built algorithms for the management of single and multiple brain metastases in patients with renal cell carcinoma. The literature review, consensus statements, and algorithms presented in this report can serve as a framework guiding treatment decisions for patients. CA Cancer J Clin. 2022;72:454-489.<br /> (© 2022 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society.)

Details

Language :
English
ISSN :
1542-4863
Volume :
72
Issue :
5
Database :
MEDLINE
Journal :
CA: a cancer journal for clinicians
Publication Type :
Academic Journal
Accession number :
35708940
Full Text :
https://doi.org/10.3322/caac.21729